Funding for this research was provided by:
Robert Bosch Stiftung
Deutsche Forschungsgemeinschaft (DFG SFB685 C05)
Deutsche Gesellschaft für Urologie (RaS1/FE-14)
ICEPHA Graduate School Tuebingen-Stuttgart
Text and Data Mining valid from 2018-07-05
Received: 14 August 2017
Accepted: 1 June 2018
First Online: 5 July 2018
Ethics approval and consent to participate
: Use of the primary tumor samples with ccRCC histology and metastases samples of patients treated at the Department of Urology, University Hospital Tuebingen, Germany, was approved by the ethics committee of the University of Tuebingen (no. 379/2010/BO2) and informed written consent was provided by each subject prior to surgical resection.
: Not applicable
: JB: consultancies, honoraria or study participation from Bayer, BMS, GSK, Immatics, Novartis, Pfizer, and Roche. AS: consultancies, honoraria or study participation from Bayer, BMS, Immatics, Novartis, Pfizer, and Roche. All other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.